Clinical Study Evaluating the Efficacy and Safety of Colchicine in Adult Patients With Sepsis

NACompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

November 1, 2023

Primary Completion Date

August 30, 2024

Study Completion Date

August 30, 2024

Conditions
Sepsis at Intensive Care Unit
Interventions
DRUG

conventional sepsis therapy alone

fluid resuscitation a minimum of 30 mL/kg of intravenous (IV) crystalloid fluid administered during the initial 3 hours of resuscitation, along with empiric antibiotic therapy aimed at the suspected pathogens and infection sites, ideally starting within the first hour.

DRUG

colchicine 500 mcg oral twice daily plus conventional sepsis therapy.

colchicine 500 mcg oral twice daily plus conventional sepsis therapy for 5 days.

Trial Locations (1)

31111

Faculty of Pharmacy - Tanta University, Tanta

All Listed Sponsors
lead

Tanta University

OTHER

NCT07074990 - Clinical Study Evaluating the Efficacy and Safety of Colchicine in Adult Patients With Sepsis | Biotech Hunter | Biotech Hunter